Oncodesign Precision Medicine S.A
Develops therapeutic and diagnostic solutions for resistant and metastatic cancers.
ALOPM | Euronext Access Plus
Overview
Corporate Details
- ISIN(s):
- FR001400CM63
- LEI:
- 969500ZDX1IY47LDL876
- Country:
- France
- Address:
- 18 RUE JEAN MAZEN, 21000 DIJON
- Website:
- https://www.oncodesign.com/
- Sector:
- Manufacturing
Description
Oncodesign Precision Medicine (OPM) is a biopharmaceutical company specializing in precision medicine. The company's mission is to develop and provide innovative therapeutic and diagnostic solutions to address therapeutic resistance and metastasis in cancer. OPM focuses on creating value through a patient-centric and translational approach, collaborating with clinicians, service providers, and experts. Its core activities are centered on discovering new treatments for resistant and metastatic cancers, aiming to identify the most effective therapeutic pathways for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-11 18:00 |
Informations privilégiées / Autres communiqués
|
French | 466.5 KB | ||
| 2025-05-06 18:00 |
Informations privilégiées / Autres communiqués
|
French | 216.8 KB | ||
| 2025-04-17 18:00 |
Inside Information / Other news releases
|
English | 341.8 KB | ||
| 2025-04-17 18:00 |
Informations privilégiées / Autres communiqués
|
French | 331.1 KB | ||
| 2025-04-03 18:00 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 364.7 KB | ||
| 2025-04-03 18:00 |
Inside Information / News release on accounts, results
|
English | 379.5 KB | ||
| 2025-03-24 18:11 |
Informations privilégiées / Autres communiqués
|
French | 540.6 KB | ||
| 2025-03-24 18:11 |
Inside Information / Other news releases
|
English | 629.3 KB | ||
| 2025-03-04 17:45 |
Nomination of Christophe Thurieau as an Independent Member of OPM Board of Dire…
|
French | 293.7 KB | ||
| 2025-03-04 17:45 |
Nomination of Christophe Thurieau as an Independent Member of OPM Board of Dire…
|
English | 287.9 KB | ||
| 2025-01-08 18:00 |
Informations privilégiées / Autres communiqués
|
French | 604.4 KB | ||
| 2024-12-20 08:00 |
Inside Information / Other news releases
|
English | 296.9 KB | ||
| 2024-12-20 08:00 |
Informations privilégiées / Autres communiqués
|
French | 284.3 KB | ||
| 2024-10-22 18:00 |
Inside Information / Other news releases
|
English | 310.0 KB | ||
| 2024-10-22 18:00 |
Informations privilégiées / Autres communiqués
|
French | 312.5 KB |
Automate Your Workflow. Get a real-time feed of all Oncodesign Precision Medicine S.A filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Oncodesign Precision Medicine S.A
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Oncodesign Precision Medicine S.A via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
